REGISTERED
on 06 Apr 2021
Last Applicant/ Owned by
Sino-Singapore Guangzhou Knowledge City
Guangzhou
CN
510006
Serial Number
88697277 filed on 18th Nov 2019
Registration Number
6316654 registered on 06th Apr 2021
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
SALMET-VEC
Chemical research; Conducting clinical trials for others; Development of pharmaceutical preparations and medicines; Inspection of pharmaceutical products for quality control purposes; Medical research; Pharmaceutical drug development services; Pharmaceutical research services; Pharmaceutical research and development; Scientific research for medical purposes in the field of cancerous diseases; Test Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Chemical research; Conducting clinical trials for others; Development of pharmaceutical preparations and medicines; Inspection of pharmaceutical products for quality control purposes; Medical research; Pharmaceutical drug development services; Pharmaceutical research services; Pharmaceutical research and development; Scientific research for medical purposes in the field of cancerous diseases; Testing of pharmaceuticals
First Use Date in General
12th Nov 2020
First Use Date in Commerce
12th Nov 2020
Mark Details
Serial Number
No 88697277
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 07th Dec 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 07th Dec 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 07th Dec 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 06th Apr 2021 | REGISTERED-PRINCIPAL REGISTER |
| 03rd Mar 2021 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 02th Mar 2021 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 26th Jan 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 26th Jan 2021 | STATEMENT OF USE PROCESSING COMPLETE |
| 06th Jan 2021 | USE AMENDMENT FILED |
| 06th Jan 2021 | TEAS STATEMENT OF USE RECEIVED |